Arstasis arterial access device recalled for faulty parts

The FDA has issued a Class I recall for Arstasis's One Access System recall device after reports that device components may separate during procedures. The device is used during femoral artery procedures for blood vessel access and to stop bleeding during the procedure.

Class I recalls are issued when a device's issue could cause serious injury or death to patients. A recall letter was sent to consumers Oct. 10, 2010, and it was posted on the FDA website Feb. 10.

- here's the Mass Device report

Suggested Articles

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.

Illumina will drop $8 billion to reacquire its former spinout, which after nearly five years is nearing completion of its cancer-seeking blood test.

The CE Mark for the system’s fourth iteration follows a July 2019 approval from the FDA.